Practice Updates in Prostate Cancer Imaging

A background on the available options and recent advances in prostate cancer imaging.

The panel explains the science behind PSMA PET scans and reviews the different positron-emitters used in the scans.

Experts review ongoing clinical trials in PSMA PET technology.

An explanation of the importance of clinical providers following a multidisciplinary approach for prostate cancer management.

Michael Gorin, MD, describes his experiences with prostate cancer imaging both in academia and community-based practices.

Doctors present the patient profile of a 66-year-old man with high-risk localized prostate cancer.

Key opinion leaders review the OSPREY clinical trial studying PSMA PET scans for prostate cancer imaging.

Authors from the OSPREY clinical trial highlight the key take-home messages from the trial outcomes.

Dr Lawrence Saperstein describes the importance of coronal images and visual analysis in making a thoughtful treatment plan for prostate cancer.

A radiation oncologist explains how to discuss the interpretation of prostate cancer imaging with patients in deciding on a treatment plan.

A look at how PSMA PET imaging fits into the monitoring of a patient with prostate cancer.

Lawrence Saperstein, MD, reviews the patient profile of a 65-year-old man with high-risk prostate cancer.

Steven Finkelstein, MD, DABR, FACRO, presents a high-risk prostate cancer patient profile for a 74-year-old man with a history of chronic prostatitis.

A panel of experts review whether bone scans still have a place in prostate cancer imaging.

Michael Gorin, MD, presents a clinical example of a 60-year-old patient with recurrent prostate cancer.

Key opinion leaders review the CONDOR clinical trial studying PSMA PET scans for prostate cancer imaging.

Dr Lawrence Saperstein describes the patient profile of a 78-year-old man with a history of intensity-modulated radiation therapy for adenocarcinoma.

Dr Steven Finkelstein explains a clinical example of a 65-year-old patient with a history of robotic radical prostatectomy for Gleason 9 adenocarcinoma.

A look at the patient profile of a 62-year-old man presenting with reduced urinary flow and hematuria.

Neal Shore, MD, FACS, reviews the VISION clinical trial in prostate cancer imaging.

Prostate cancer experts highlight some closing thoughts and exciting research in progress on prostate cancer imaging.